SEARCH

SEARCH BY CITATION

REFERENCES

  • Abe K., Tanzi R. E., and Kogure K. (1991a) Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125, 172174.
  • Abe K., St. George-Hyslop P. H., Tanzi R. E., and Kogure K. (1991b) Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci. Lett. 125, 169171.
  • Albrecht J. and Yanagihara T. (1979) Effect of anoxia and ischaemia on ribonuclease activity in brain. J. Neurochem. 32, 11311133.
  • Aniello F., Couchie D., Bridoux A.-M., Gripois D., and Nunez J. (1991) Splicing of juvenile and adult tau mRNA variants is regulated by thyroid hormone. Proc. Natl. Acad. Sci. USA 88, 40354039.
  • Arai H., Noguchi I., Sagi N., Moroji T., and Iizuka R. (1989) A study of non-isotopic in situ hybridization histochemistry oh postmortem changes in vasopressin mRNA in rat brain. Neurosci. Lett. 103, 127132.
  • Atwater J. A., Wisdom R., and Verma I. M. (1990) Regulated mRNA stability. Annu. Rev. Genet. 24, 519541.
  • Barton A. J. L. and Hardy J. A. (1987) Stability of brain RNA post mortem: effect of Alzheimer's disease. Biochem. Soc. Trans. 15, 558559.
  • Benfenati F., Cimino M., Zoli M., Grimaldi R., Zini I., and Agnati L. F. (1991) Increase in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischaemia. Neurosci. Lett. 126, 68.
  • Bernstein P. and Ross J. (1989) PoIy(A), poly(A) binding protein and the regulation of mRNA stability. Trends Biochem. Sci. 14, 373377.
  • Bird R. C. (1986) Selective loss of small RNAs during isolation by the guanidium thiocyanate/cesium chloride gradient method. Bio Techniques 4, 202204.
  • Bowen D. M., Smith C. L., White P., and Davison A. N. (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459496.
  • Brawerman G. (1990) Mechanisms of mRNA decay. Trends Biotechnol. 8, 171174.
  • Burke W. J., O'Malley K. L., Chung H. D., Harmon S. K., Miller P., and Berg L. (1991) Effect of pre-and postmortem variables on specific mRNA levels in human brain. Mol. Brain Res. 11, 3741.
  • Clark A. W., Krekoski C. A., Parhad I. M., Liston D., Julien J.-P., and Hoar D. I. (1989) Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann. Neurol. 25, 331339.
  • Clark A. W., Tran P. M., Parhad I. M., Krekoski C. A., and Julien J.-P. (1990) Neuronal gene expression in amyotrophic lateral sclerosis. Mol. Brain Res. 7, 7583.
  • Daval J.-L., Nakajima T., Gleiter C. H., Post R. M., and Marangos P. J. (1989) Mouse brain c-fos mRNA distribution following a single electroconvulsive shock. J. Neurochem. 52, 19541957.
  • De la Concha A., McKie J., Hodgkinson S., Mankoo B. S., and Gurling H. M. G. (1991) Stereospecific effect of flupenthixol on neuroreceptor gene expression. Mol. Brain Res. 10, 123127.
  • Dodd P. R., Hambley J. W., Cowburn R. F., and Hardy J. A. (1988) A comparison of methodologies for the study of functional transmitter neurochemistry in human brain. J. Neurochem. 50, 13331345.
  • Dziegielewska K. M., Saunders N. R., Schejter E. J., Zakut H., Zevin-Sonkin D., Zisling R., and Soreq H. (1986) Synthesis of plasma proteins in fetal, adult and neoplastic brain tissue. Dev. Biol. 115, 93104.
  • Ernfors P., Lindefors N., Chan-Palay V., and Persson H. (1990) Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia 1, 138145.
  • Gall C., Lauterborn J., Isackson P., and White J. (1990) Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog. Brain Res. 83, 371390.
  • Gallie D. R. (1991) The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev. 5, 21082116.
  • Geddes J. W., Wong J., Choi B. H., Kim R. C., Cotman C. W., and Miller F. D. (1990) Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's disease. Neurosci. Lett. 109, 5461.
  • Gilbert J. M., Brown B. A., Strocchi P., Bird E. D., and Marotta C. A. (1981) The preparation of biologically active messenger RNA from human post mortem brain tissue. J. Neurochem. 36, 976984.
  • Griffin W. S. T., Ling C., White C. L. III, and Morrison-Bogorad M. (1990) Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 4, 6978.
  • Guillemette J. G., Wong L., Crapper McLachlan D. R., and Lewis P. N. (1986) Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain. J. Neurochem. 47, 987997.
  • Hardy J. A., Wester P., Winblad B., Gezelius C., Bring G., and Eriksson A. (1985) The patients dying after long terminal phase have acidotic brain: implications for biochemical measurements on autopsy tissue. J. Neural Transm. 61, 253264.
  • Hargrove J. L. and Schmidt F. H. (1989) The role of mRNA and protein stability in gene expression. FASEB J. 3, 23602370.
  • Harrison P. J. (1993) Expression of the β-amyloid precursor protein gene and the pathogenesis of Alzheimer's disease, in Basic and Clinical Aspects of Neuroscience, Vol. 6: Regulation of Gene Expression and Brain Function (WeilC., MüllerE., ThornerM., and HarrisonP. J., eds) (in press). Springer Verlag, Berlin .
  • Harrison P. J. and Pearson R. C. A. (1990) In situ hybridization histochemistry and the study of gene expression in the human brain. Prog. Neurobiol. 34, 271312.
  • Harrison P. J., Barton A. J. L., Najlerahim A., and Pearson R. C. A. (1990) Distribution of a kainate/AMPA receptor mRNA in normal and Alzheimer brain. Neuro Report 1, 149152.
  • Harrison P. J., Procter A. W., Barton A. J. L., Lowe S., Najlerahim A., Bertolucci P. H. F., Bowen D. M., and Pearson R. C. A. (1991a) Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Mol. Brain Res. 9, 161164.
  • Harrison P. J., Barton A. J. L., Najlerahim A., McDonald B., and Pearson R. C. A. (1991b) Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry. Mol. Brain Res. 9, 1521.
  • Harrison P. J., Barton A. J. L., McDonald B., and Pearson R. C. A. (1991c) Alzheimer's disease: specific increases in a G protein subunit (G) mRNA in hippocampal and cortical neurons. Mol. Brain Res. 10, 7181.
  • Harrison P. J., Barton A. J. L., Najlerahim A., McDonald B., and Pearson R. C. A. (1991d) Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease. Psychol. Med. 21, 855866.
  • Harrison P. J., Procter A. W., Exworthy T., Najlerahim A., Barton A. J. L., and Pearson R. C. A. (1993) Heat shock protein (hsx70) mRNA expression in human brain: effects of neurode-generative disease and agonal state. Neuropathol. Appl. Neurobiol. 19, 1021.
  • Javoy-Agid F., Hirsch E. C., Dumas S., Duyckaerts C., Mallet J., and Agid Y. (1990) Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 38, 245253.
  • Johnson S. A., Morgan D. G., and Finch C. E. (1986) Extensive postmortem stability of RNA from rat and human brain. J. Neurosci. Res. 16, 267280.
  • Jorgensen M. B., Deckert J., Wright D. C., and Gehlert D. R. (1989) Delayed c-fos protooncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study. Brain Res. 484, 393398.
  • Kobayashi H., Sakimura K., Kuwano R., Sato S., Ikuta F., Takahashi Y., Miyatake T., and Tsuji S. (1990) Stability of messenger RNA in postmortem human brains and construction of human brain cDNA libraries. J. Mol. Neurosci. 2, 2934.
  • Långstrom N. S., Anderson J. P., Lindroos H. G., Winblad B., and Wallace W. C. (1989) Alzheimer's disease-associated reduction of polysomal mRNA translation. Mol. Brain Res. 5, 259269.
  • Långstrom N. S., Eriksson A., Winblad B. G., and Wallace W. C. (1990) Characterization of polysomes purified from human postmortem brain tissues. Neurochem. Int. 16, 147156.
  • Lausson S., Segond N., Milhaud G., and Staub J. F. (1989) Circadian rhythms of calcitonin gene expression in the rat. J. Endocrinol. 122, 527534.
  • Leonard S., Logel J., Luthman D., Casanova M., Kirch D., and Freedman R. (1991) Parameters affecting the use of human postmortem brain for molecular biological studies. Soc. Neurosci. Abstr. 17, 379.
  • Lightman S. L. and Young W. S., III (1987) Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature 328, 643647.
  • Lukiw W. J., Wong L., and McLachlan D. R. C. (1990) Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease. Int. J. Neurosci. 55, 8188.
  • Mengod G., Charli J.-L., and Palcios J. M. (1990) The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain. Cell. Mol. Neurobiol. 10, 113126.
  • Mengod G., Vivanco M. M., Christnacher A., Probst A., and Palacios J. M. (1991) Study of pro-opiomelanocortin mRNA expression in human postmortem pituitaries. Mol. Brain Res. 10, 129137.
  • Mochly-Rosen D., Chang F.-H., Cheever L., Kim M., Diamond I., and Gordon A. S. (1988) Chronic ethanol causes heterologous desensitization of receptors by reducing αs messenger RNA. Nature 333, 848850.
  • Morgan D. G., Finch C. E., and Johnson S. A. (1991) RNA metabolism in Alzheimer's disease: selective increase in GFAP RNA, in Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies (IqbalK., McLachlanD. R. C., WinbladB., and WisniewskiH. M., eds), pp. 407416. John Wiley, Chichester .
  • Morrison M. R. and Griffin W. S. T. (1981) The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain. Anal. Biochem. 113, 318324.
  • Müller-Hill B. and Beyreuther K. (1989) Molecular biology of Alzheimer's disease. Annu. Rev. Biochem. 58, 287307.
  • Murthy M. R. V. (1982) Effects of cap analogue or cap removal on the translation of rat brain mRNA in vitro. J. Neurochem. 38, 4151.
  • Naber D. and Dahnke H. G. (1979) Protein and nucleic acid content in the aging human brain. Neuropathol. Appl. Neurobiol. 5, 1724.
  • Nichols N. R., Masters J. N., and Finch C. E. (1990) Changes in gene expression in hippocampus in response to glucocorticoids and stress. Brain Res. Bull. 24, 659662.
  • Nishimori T., Buzzi M. G., Moskowitz M. A., and Uhl G. R. (1989) Preproenkephalin mRNA expression in nucleus caudalis neurons is enhanced by trigeminal stimulation. Mol. Brain Res. 6, 203210.
  • Noguchi I., Arai H., and Iizuka R. (1991) A study on postmortem stability of vasopressin messenger RNA in rat brain compared with those in total RNA and ribosomal RNA. J. Neural Transm. [Gen. Sect.] 83, 171178.
  • Nowak T. S. Jr., Bond U., and Schlesinger M. J. (1990) Heat shock mRNA levels in brain and other tissues after hyperthermia and transient ischaemia. J. Neurochem. 54, 451458.
  • Octave J.-N., De Sauvage F., Macq A.-F., and Maloteaux J.-M. (1988) Cloning of the cDNA from normal brain and brain from patients with Alzheimer's disease in the expression vector lambda gt11. Prog. Neuropsychopharmacol. Biol. Psychiatry 12, 813820.
  • Oyama F., Shimada H., Oyama R., Titani K., and Ihara Y. (1991) Differential expression of β amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau. J. Neuropathol. Exp. Neurol. 50, 560578.
  • Palmer A. M., Lowe S. L., Francis P. T., and Bowen D. M. (1988) Are post-mortem biochemical studies of human brain worthwhile Biochem. Soc. Trans., 16, 472475.
  • Pearson R. C. A., Barton A. J. L., Heath P. R., Arid Harrison P. J. (1992) Changes in messenger RNA in dementia, in Neurodegeneration (HunterA. J. and ClarkM., eds), pp. 151165. Academic Press, London .
  • Perrett C. W., Marchbanks R. M., and Whatley S. A. (1988) Characterisation of messenger RNA extracted from the brains of schizophrenic, depressed and control subjects. J. Neurol. Neurosurg. Psychiatry 51, 325331.
  • Perrett C. W., Whatley S. A., Ferrier I. N., and Marchbanks R. M. (1992) Changes in brain gene expression in schizophrenic and depressed patients. Schizophr. Res. 6, 193200.
  • Perry E. K., Gibson P. H., Blessed G., Perry R. H., and Tomlinson B. E. (1977) Neurotransmitter enzyme abnormalities in senile dementia. J. Neurol. Sci. 34, 247265.
  • Phillips H. S., Hains J. M., Armanini M., Laramee G. R., Johnson S. A., and Winslow J. W. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695702.
  • Procter A. W., Doshi B., Bowen D. M., and Murphy E. (1990) Rapid autopsy brains for biochemical research: experiences in establishing a programme. Int. J. Geriat. Psychiatry 5, 287294.
  • Ragsdale D. S. and Miledi R. (1991) Expressional potency of mRNAs encoding receptors and voltage-activated channels in the postmortem rat brain. Proc. Natl. Acad. Sci. USA 88, 18541858.
  • Reichert G. H. and Issinger O.-G. (1985) In vitro study of the biological activity of RNAs after incubation of hog liver, heart and brain tissue at room temperature. Biochimie 67, 657661.
  • Rivkees S. A., Chaar M. R., Hanley D., Maxwell M., Reppert S. M., and Uhl G. R. (1989) Localization and regulation of vasopressin mRNA in human neurons. Synapse 3, 246254.
  • Romano G. J., Shivers B. D., Harlan R. E., Howells R. D., and Pfaff D. W. (1987) Haloperidol increases preproenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization histochemistry. Mol. Brain Res. 2, 3341.
  • Roses A. D. (1986) The impact of molecular genetics on clinical neurology. Trends Neurosci. 9, 518522.
  • Ross B. M., Knowler J. T., and McCulloch J. (1992) On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J. Neurochem. 58, 18101819.
  • Saffen D. W., Cole A. J., Worley P. F., Christy B. A., Ryder K., and Baraban J. M. (1988) Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc. Natl. Acad Sci. USA 85, 77957799.
  • Saini K. S., Summerhayes I. C., and Thomas P. (1990) Molecular events regulating messenger RNA stability in eukaryotes. Mol. Cell. Biochem. 96, 1523.
  • Saito N., Guitart X., Hayward M., Tallman J. F., Duman R. S., and Nestler E. J. (1989) Corticosterone differentially regulates the expression of Gsalpha and Gialpha messenger RNA and protein in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 86, 39063910.
  • Sajdel-Sulkowska E. M. and Marotta C. A. (1984) Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science 228, 947949.
  • Sajdel-Sulkowska E. M., Majocha R. E., Salim M., Zain S. B., and Marotta C. A. (1988) The postmortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA. J. Neurosci. Methods 23, 173179.
  • Savasta M., Palacios J. M., and Mengod G. (1990) Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization. Mol. Brain Res. 7, 91104.
  • Somerville M. J., Percy M. E., Bergeron C., Yoong L. K. K., Grima E. A., and McLachlan D. R. C. (1991) Localization and quantitation of 68-kDa neurofilament and superoxide dismutase-1 mRNA in Alzheimer brains. Mol. Brain Res. 9, 18.
  • Spokes E. G. and Koch D. J. (1978) Post-mortem stability of dopamine, glutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material. J. Neurochem. 31, 381383.
  • Sprang G. K. and Brown I. R. (1987) Selective induction of a heat shock gene in fibre tracts and cerebellar neurons of the rabbit brain detected by in situ hybridization. Mol. Brain Res. 3, 8993.
  • Steward O., Torre E. R., Tomasulo R., and Lothman E. (1991) Neuronal activity up-regulates astroglial gene expression. Proc. Natl. Acad. Sci. USA 88, 68196823.
  • Suda T., Tozawa F., Yamada M., Ushiyama T., Tomori N., Sumitomo T., Nakagami Y., Demura H., and Shizume K. (1988) Insulin-induced hypoglycaemia increases corticotropin-releasing factor messenger ribonucleic acid levels in rat hypothalamus. Endocrinology 123, 13711375.
  • Taylor G. R., Carter G. I., Crow T. J., Johnson J. A., Fairbairn A. F., Perry E. K., and Perry R. H. (1986) Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Exp. Mol. Pathol. 44, 111116.
  • Whitehouse P. J., Lynch D., and Kuhar M. J. (1984) Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process. J. Neurochem. 43, 553559.
  • Wiesner R. J. and Zak R. (1991) Quantitative approaches for studying gene expression. Am. J. Physiol. 260, L179L188.
  • Wood T. L., Frantz G. D., Menkes J. H., and Tobin A. H. (1986) Regional distribution of messenger RNAs in post mortem human brain. J. Neurosci. Res. 16, 311324.
  • Yates C. M., Butterworth J., Tennant M. C., and Gordon A. (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem. 55, 16241630.
  • Yost H. J., Petersen R. B., and Lindquist S. (1990) RNA metabolism: strategies for regulation in the heat shock response. Trends Genet. 6, 223227.
  • Zain S. B., Salim M., Chou W.-G., Sajdel-Sulkowska E. M., Majocha R. E., and Marotta C. A. (1988) Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex. Proc. Natl. Acad. Sci. USA 85, 929933.